Often called the master gland for its role regulating multiple hormone systems throughout the body, the pituitary sits at the base of the brain in a small bony structure. Its anterior lobe contains several distinct cell types, each responsible for a different hormone.
The somatotroph cells within the anterior lobe are specifically responsible for synthesizing and secreting growth hormone, making them the sole natural source of GH anywhere in the human body — no other tissue produces it.
Somatotrophs do not operate independently; they respond to signals sent from the hypothalamus, the brain region immediately above the pituitary. Growth hormone-releasing hormone (GHRH) stimulates secretion, while somatostatin suppresses it — two opposing signals whose balance sets the pulsatile rhythm characteristic of GH release.
This dual-signal control system is a documented feature of hypothalamic-pituitary regulation generally, not unique to growth hormone, but it is particularly well characterized in the GH axis specifically.
Rising levels of both GH and downstream IGF-1 signal back to the hypothalamus and pituitary, increasing somatostatin release and reducing further secretion. This closed loop keeps growth hormone signaling within a normal physiological range under healthy conditions.
This feedback mechanism is what makes the axis self-regulating rather than requiring external control, and it is precisely the mechanism that breaks down in both deficiency and excess states.
Damage to either the pituitary itself or the hypothalamic signaling pathway — from a tumor, surgery, radiation, or traumatic injury — is the most commonly documented cause of acquired growth hormone deficiency in adults, since it disrupts the somatotrophs' ability to respond normally.
This is general endocrine physiology published for research-education purposes. REVIVE LAB UAE does not sell HGH and this article makes no clinical or product claim.